United Therapeutics | UTHR - Market Capitalization


United Therapeutics reported $27.56B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 290M 51M Dec/2025
Ardelyx USD 1.48B 63M Mar/2026
Baxter International USD 11.01B 2.34B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Gilead Sciences USD 196.01B 39.15B Oct/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Insmed USD 14.12B 8.99B Oct/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 607B 46.61B Oct/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
PTC Therapeutics USD 4.83B 1.97B Oct/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026